pharma news

News

Intellia shares fall after hospitalised CRISPR patient dies

Shares in gene-editing specialist Intellia Therapeutics came under renewed pressure today after a patient in one of its clinical trials died.

News

Braveheart, AAVantgarde rounds head recent biofinancings

Our latest crop of biotech financings has nine-figure rounds for Braveheart and AAVantgarde, with Azalea Therapeutics and NEOK Bio also raising funds.

News

Eisai settles Lenvima patent dispute with Torrent Pharma

A settlement between Eisai and Torrent Pharma will keep a generic version of blockbuster cancer drug Lenvima off the US market until 2030.

News

GLP-1s feature in second batch of national priority vouchers

GLP-1 drugs for weight loss, cancer, and rare diseases feature among the latest crop of medicines awarded priority vouchers by the FDA.

News

Company representatives with President Trump in the Oval Office

Novo, Lilly sign MFN pricing deal with Trump administration

The pricing agreement between Novo Nordisk and Eli Lilly and the Trump administration on GLP-1 drugs for diabetes and obesity has arrived.

News

J&J adds first new indication for Caplyta since takeover

Johnson & Johnson has clinched an FDA approval for Caplyta in depression, satisfying a major driver for its $14.6bn takeover of ICT this year.

Intellia shares fall after hospitalised CRISPR patient dies

Braveheart, AAVantgarde rounds head recent biofinancings

Eisai settles Lenvima patent dispute with Torrent Pharma

GLP-1s feature in second batch of national priority vouchers

Novo, Lilly sign MFN pricing deal with Trump administration

J&J adds first new indication for Caplyta since takeover

Biotech is back, with Craig Ackerman

Using AI-driven synthetic personas to take your insights fur...

pharma news

Editor's Picks